IL-24 contributes to skin inflammation in Para-Phenylenediamine-induced contact hypersensitivity.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
12 02 2019
Historique:
received: 28 06 2018
accepted: 19 12 2018
entrez: 14 2 2019
pubmed: 14 2 2019
medline: 24 9 2020
Statut: epublish

Résumé

Para-Phenylenediamine (PPD) is an aromatic amine used in hair dyes and in temporary black henna tattoos, which is a frequent cause of allergic contact dermatitis (ACD). ACD is a skin inflammatory reaction characterized by modifications such as spongiosis, exocytosis and acanthosis. The aim of this study is to characterize the expression and the role of IL-20-related cytokines, including IL-19, IL-20, IL-22 and IL-24, in ACD. The expression of IL19, IL20, IL22 and IL24 is increased in affected skin from PPD allergic patients compared with uninvolved skin. In addition, the expression of these cytokines positively correlates with clinical symptoms. To assess their role in ACD, we set up a mouse model of PPD-induced allergic contact dermatitis and we showed that, in contrast to Il22-deficient mice, Il22ra1-, Il20rb- and Il24-deficient mice are partially protected against development of PPD-induced contact hypersensitivity. These mice have decreased ear thickening and less acanthosis compared with WT mice after PPD treatment. In addition, the absence of IL-22R, IL-20R2 or IL-24 affects the recruitment of neutrophils into the skin but not the total IgE production. Taken together, these results demonstrate the implication of IL-24 via the IL-20R type II receptor in the inflammatory process of ACD.

Identifiants

pubmed: 30755657
doi: 10.1038/s41598-018-38156-4
pii: 10.1038/s41598-018-38156-4
pmc: PMC6372603
doi:

Substances chimiques

Coloring Agents 0
Cytokines 0
Il24 protein, mouse 0
Interleukins 0
Phenylenediamines 0
Receptors, Interleukin 0
interleukin-20 receptor 0
interleukin-22 receptor 0
interleukin-24 0
Immunoglobulin E 37341-29-0
Leukocyte Common Antigens EC 3.1.3.48
4-phenylenediamine U770QIT64J
interleukin 20 U91R7IMG8U

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1852

Références

Contact Dermatitis. 1999 Dec;41(6):348-9
pubmed: 10617223
Cell. 2001 Jan 12;104(1):9-19
pubmed: 11163236
J Immunol. 2001 Oct 1;167(7):3545-9
pubmed: 11564763
J Biol Chem. 2002 Dec 6;277(49):47517-23
pubmed: 12351624
Immunity. 2002 Sep;17(3):375-87
pubmed: 12354389
Clin Dermatol. 2003 Mar-Apr;21(2):95-100
pubmed: 12706326
Clin Exp Immunol. 2003 Jun;132(3):385-92
pubmed: 12780683
J Immunol. 2004 Dec 1;173(11):6712-8
pubmed: 15557163
Exp Dermatol. 2006 Dec;15(12):991-1004
pubmed: 17083366
Contact Dermatitis. 2007 Jan;56(1):56-7
pubmed: 17177720
J Immunol. 2007 Feb 15;178(4):2229-40
pubmed: 17277128
Clin Exp Immunol. 2007 Dec;150(3):407-15
pubmed: 17900301
J Immunol. 2007 Dec 15;179(12):8098-104
pubmed: 18056351
J Allergy Clin Immunol. 2009 Feb;123(2):486-92
pubmed: 18986691
Contact Dermatitis. 2008 Dec;59(6):327-43
pubmed: 19076884
J Immunol. 2009 Jan 15;182(2):802-10
pubmed: 19124723
Contact Dermatitis. 2009 Jan;60(1):57-8
pubmed: 19125725
J Mol Med (Berl). 2009 May;87(5):523-36
pubmed: 19330474
J Immunol. 2009 Jul 15;183(2):1463-70
pubmed: 19553527
Br J Dermatol. 2010 Jan;162(1):102-7
pubmed: 19785606
J Immunol. 2010 Feb 15;184(4):1793-8
pubmed: 20061404
Immunopharmacol Immunotoxicol. 2010 Dec;32(4):700-4
pubmed: 20235740
Annu Rev Immunol. 2011;29:71-109
pubmed: 21166540
J Immunotoxicol. 2011 Jan-Mar;8(1):46-55
pubmed: 21299354
J Immunol. 2011 Apr 1;186(7):4098-109
pubmed: 21357535
Immunity. 2011 Oct 28;35(4):596-610
pubmed: 21982596
J Immunol. 2012 Jan 1;188(1):462-9
pubmed: 22131335
APMIS. 2012 Jan;120(1):1-27
pubmed: 22151305
Nat Rev Immunol. 2012 Jan 13;12(2):114-24
pubmed: 22240625
Adv Skin Wound Care. 2012 Aug;25(8):371-80; quiz 381-2
pubmed: 22820963
J Invest Dermatol. 2013 Feb;133(2):303-15
pubmed: 22931926
Contact Dermatitis. 2013 Jun;68(6):339-47
pubmed: 23692034
Allergy. 2014 Jan;69(1):125-31
pubmed: 24372156
J Invest Dermatol. 2014 Nov;134(11):2757-2767
pubmed: 25046339
Clin Exp Dermatol. 2014 Dec;39(8):924-31
pubmed: 25196929
Nat Rev Immunol. 2014 Dec;14(12):783-95
pubmed: 25421700
J Exp Med. 2015 Jan 12;212(1):15-22
pubmed: 25512469
J Invest Dermatol. 2016 Feb;136(2):409-415
pubmed: 26802237
J Invest Dermatol. 2017 May;137(5):1094-1103
pubmed: 28115058
Clin Exp Immunol. 2017 Sep;189(3):342-351
pubmed: 28369789
PLoS One. 2017 Apr 20;12(4):e0175802
pubmed: 28426699
Contact Dermatitis. 2017 Jul;77(1):1-16
pubmed: 28497472
J Allergy Clin Immunol. 2018 Jan;141(1):152-162
pubmed: 28583370
Curr Allergy Asthma Rep. 2017 Nov 11;17(12):83
pubmed: 29129023
J Immunol. 1997 Sep 1;159(5):2484-91
pubmed: 9278342

Auteurs

Astrid B Van Belle (AB)

de Duve Institute, Université catholique de Louvain, Brussels, Belgium.

Perrine M Cochez (PM)

de Duve Institute, Université catholique de Louvain, Brussels, Belgium.

Magali de Heusch (M)

de Duve Institute, Université catholique de Louvain, Brussels, Belgium.

Lisa Pointner (L)

de Duve Institute, Université catholique de Louvain, Brussels, Belgium.

Remi Opsomer (R)

Institut de Neurosciences, Université catholique de Louvain, Brussels, Belgium.

Peggy Raynaud (P)

de Duve Institute, Université catholique de Louvain, Brussels, Belgium.

Younes Achouri (Y)

de Duve Institute, Université catholique de Louvain, Brussels, Belgium.

Emilie Hendrickx (E)

de Duve Institute, Université catholique de Louvain, Brussels, Belgium.

Pamela Cheou (P)

de Duve Institute, Université catholique de Louvain, Brussels, Belgium.

Guy Warnier (G)

Ludwig Institute for Cancer Research, Brussels branch, Brussels, Belgium.

Jean-Christophe Renauld (JC)

de Duve Institute, Université catholique de Louvain, Brussels, Belgium.

Marie Baeck (M)

Department of Dermatology, Cliniques Universitaires Saint-Luc, UCL, B-1200, Brussels, Belgium.
Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium.

Laure Dumoutier (L)

de Duve Institute, Université catholique de Louvain, Brussels, Belgium. laure.dumoutier@uclouvain.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH